Diagnosing Osteoporosis

Published Online: Wednesday, June 20, 2012
Follow Pharmacy_Times:
In this podcast, Shreyasee Amin, MD, of the Mayo Clinic, discusses the recommended schedule for bone density tests to detect osteoporosis. Typically, physicians suggest the test at age 65 for women and 70 for men, although certain risk factors can require earlier testing, Dr. Amin says. She notes some of the common risk factors for osteoporosis, including use of steroids, and discusses some preventive measure patients can take, such as daily calcium and vitamin D supplements, and exercise.
 
To download the podcast, click here.
Related Articles
Supplementation with alkaline potassium salts aids bone health and reduces osteoporosis risk.
Women who take bisphosphonates, which are commonly used to treat osteoporosis and other bone conditions, have about half the risk of developing endometrial cancer as women who do not use the drugs. This study supports other research showing that bisphosphonates may have an anticancer effect.
The media has been quick to discuss research findings on vitamin D supplementation’s potential role in combating osteoporosis, correcting deficiency in chronic kidney disease, improving heart health, and extending life, which raises the question of whether patients should be screened routinely for vitamin D deficiency.
Well-trained pharmacy technicians can free up pharmacists’ time for osteoporosis management services by identifying patients who do not require pharmacist intervention.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$